The rise in antibiotic resistance among bacterial pathogens has rekindled the threat of infectious disease and accompanying morbidity and mortality. Thus, it is imperative that we develop new strategies to combat bacterial infections. Further, new understanding of the beneficial roles of normal host microbiota in human nutrition, immunology and health suggests that targeted therapies that eliminate harmful bacteria from sites of infection without affecting beneficial microbes are needed. One promising strategy for developing such treatments is to intervene in the mechanisms by which pathogens colonize the particular niches in which they cause infection. An important mechanism affecting the tropisms of a wide range of Gram-negative bacteria is the elaboration of adhesive extracellular fibers called chaperone-usher pathway (CUP) pili. One of the best studied of these systems is type 1 pili and its mannose binding adhesin, FimH, which is critical for host pathogen interactions throughout the course of urinary tract infections (UTIs). UTI: i) is one of the most common bacterial infections; ii) primarily affects otherwise healthy females (50% of women will have a UTI) and; iii) is highly recurrent and is associated with significant morbidity and economic impact, with over $2.5 billion spent annually on treatment. Uropathogenic E. coli (UPEC), the causative agent of ~80% of UTIs, is becoming increasingly antibiotic-resistant. Structural, genetic and biophysical studies have defined the binding interactions between mannose and FimH and indicate that conformational equilibria within FimH regulate its function and role in UTI pathogenesis. Surprisingly, little to nothing is known regarding the structure, function and mechanism of action of the majority of common UPEC CUP adhesins. Therefore, this proposal will elucidate the structures and functions of the two-domain CUP adhesins from two prototypical UPEC strains, used widely to study UTIs: i) UTI89 (a human clinical cystitis isolate) and ii) CFT073 (a human clinical pyelonephritis/urosepsis isolate. Each of these strains encodes complete CUP pilus assembly operons for type 1, Yqi, Yfc1, P, F1C/S, Yeh, Yad3, and Mat pili. In addition, UTI89 encodes a complete F17-like CUP operon and CFT073 encodes complete F9 (Fml) and Auf CUP operons. This proposal will study how conformational equilibria of the FimH adhesin and the FimA rod of the type 1 pilus impact host-pathogen interactions critical in pathogenesis (Aim 1) and determine the function of common UPEC two-domain CUP adhesins, determining UPEC adhesin tissue tropisms, ligand specificity, structure-function correlates and conformational dynamics (Aim 2). This proposal will also investigate structure/function correlates within the family of FimH-like adhesins, revealing likely evolutionary steps leading from one binding specificity to another within the family of FimH-like adhesins and characterizing the probable influence of host innate immunity on natural selection in adhesins (Aim 3). The successful completion of this proposal will give a holistic view into the functional CUP piliome of UPEC, providing new insights into the dynamic function of pili and development of novel therapeutics.

Public Health Relevance

The adhesins of Chaperone Usher Pathway (CUP) pili, which are ubiquitous in Gram-negative bacteria, are critical mediators of tissue tropism and thus initiation of disease. Strains of uropathogenic E. coli (UPEC), which cause the majority of urinary tract infections, typically encode ~10 different adhesive CUP pili in their genome. We seek to better understand tissue tropisms, and how the interplay between protein sequence and the structural dynamics of conformational equilibria governs binding events. These studies are critical for our understanding of UPEC's ability to inhabit multiple host niches and cause disease, and may provide the key to developing targeted therapies to block UPEC colonization and subsequent infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI048689-17
Application #
9187827
Study Section
Bacterial Pathogenesis Study Section (BACP)
Program Officer
Ernst, Nancy Lewis
Project Start
2001-02-01
Project End
2021-01-31
Budget Start
2017-02-01
Budget End
2018-01-31
Support Year
17
Fiscal Year
2017
Total Cost
$383,019
Indirect Cost
$120,858
Name
Washington University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Kalas, Vasilios; Pinkner, Jerome S; Hannan, Thomas J et al. (2017) Evolutionary fine-tuning of conformational ensembles in FimH during host-pathogen interactions. Sci Adv 3:e1601944
Sheikh, Alaullah; Rashu, Rasheduzzaman; Begum, Yasmin Ara et al. (2017) Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions. PLoS Negl Trop Dis 11:e0005586
Spaulding, Caitlin N; Klein, Roger D; Ruer, Ségolène et al. (2017) Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist. Nature 546:528-532
Paharik, Alexandra E; Schreiber 4th, Henry L; Spaulding, Caitlin N et al. (2017) Narrowing the spectrum: the new frontier of precision antimicrobials. Genome Med 9:110
O'Brien, Valerie P; Hannan, Thomas J; Nielsen, Hailyn V et al. (2016) Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. Microbiol Spectr 4:
Spaulding, Caitlin N; Hultgren, Scott J (2016) Adhesive Pili in UTI Pathogenesis and Drug Development. Pathogens 5:
Hospenthal, Manuela K; Redzej, Adam; Dodson, Karen et al. (2016) Structure of a Chaperone-Usher Pilus Reveals the Molecular Basis of Rod Uncoiling. Cell 164:269-278
Hibbing, Michael E; Conover, Matt S; Hultgren, Scott J (2016) The unexplored relationship between urinary tract infections and the autonomic nervous system. Auton Neurosci 200:29-34
Conover, Matt S; Ruer, Ségolène; Taganna, Joemar et al. (2016) Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection. Cell Host Microbe 20:482-492
O'Brien, Valerie P; Hannan, Thomas J; Schaeffer, Anthony J et al. (2015) Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr Opin Infect Dis 28:97-105

Showing the most recent 10 out of 73 publications